Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Misael Alonso

Undersea and Hyperbaric Medicine Surprise, AZ Medical Doctor

NPI 1487603312 CMS profile 804198

14955 W Bell Rd Unit 9080, Surprise, AZ 85374

Open in the dashboard

General payments

$20,701

204 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Misael Alonso of Surprise, AZ is reported in the CMS Open Payments database as having received $20,701 across 204 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Undersea and Hyperbaric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $14,408 51
2024 General $1,586 35
2023 General $820 35
2022 General $2,784 41
2021 General $746 26
2020 General $357 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Misael Alonso
  • Undersea and Hyperbaric Medicine median
  • Middle half of Undersea and Hyperbaric Medicine
  • National median

In program year 2025, general payments to Misael Alonso were reported at $14,408. Among 121 Undersea and Hyperbaric Medicine profiles paid that year, the median was $208 and the middle half received between $52 and $518.

Show as a table
Year Misael Alonso Undersea and Hyperbaric Medicine median Middle half National median
2019 $0 $201 $85–$538 $163
2020 $357 $84 $31–$222 $114
2021 $746 $138 $52–$383 $132
2022 $2,784 $135 $51–$385 $149
2023 $820 $143 $75–$442 $160
2024 $1,586 $178 $80–$442 $164
2025 $14,408 $208 $52–$518 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Solventum Corporation $13,193 16 payments
  2. KCI USA, Inc $2,386 17 payments
  3. Organogenesis Inc. $1,162 48 payments
  4. Smith+Nephew, Inc. $1,043 57 payments
  5. Musculoskeletal Transplant Foundation Inc. $934 7 payments
  6. Integra LifeSciences Corporation $429 8 payments
  7. Urgo Medical North America, LLC $232 3 payments
  8. MIMEDX Group, Inc. $224 7 payments
  9. AbbVie, Inc. $183 9 payments
  10. Hydrofera LLC $178 7 payments
  11. Other $735 25 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,563 4 payments
  2. Food and Beverage $5,021 190 payments
  3. Consulting Fee $2,924 3 payments
  4. Travel and Lodging $1,864 4 payments
  5. Long term medical supply or device loan $308 2 payments
  6. Education $21 1 payment
Products named General payments · program years 2020–2025
  1. V.A.C. VERAFLO $9,501 10 payments
  2. PREVENA $6,683 9 payments
  3. 3M SoluPrep $4,258 2 payments
  4. ACTIV.A.C. $2,408 10 payments
  5. V.A.C. DERMATAC $2,068 9 payments
  6. KerraLite Cool $650 1 payment
  7. APLIGRAF $396 19 payments
  8. PROMOGRAN PRISMA $359 3 payments
  9. Puraply $314 14 payments
  10. DuraGen $308 2 payments
  11. Other $4,633 175 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$34,867

Medicare's payments for the services billed

Medicare patients

51

Average age 76

Services billed

617

20 women, 31 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 71%
Ischemic heart disease 61%
Chronic kidney disease 57%
Diabetes 55%
Heart failure 49%
Atrial fibrillation 41%
Cancer 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

204 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Undersea and Hyperbaric Medicine in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record